Login / Signup

Evaluation of Transarterial Chemoembolization Protocol with Drug-Eluting Beads in Combination with Lipiodol for Hepatocellular Carcinoma: A Single-Center Controlled Study.

Xiangjun DongYing WangJieya HaoLei ChenTao SunWeihua ZhangBo SunLicheng ZhuYusheng GuoChuangsheng Zheng
Published in: Journal of oncology (2022)
DEB-Lipiodol TACE was safe, well tolerated, and had a better efficacy compared with DEB-TACE in unresectable HCC patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • randomized controlled trial
  • liver metastases
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • radiation therapy